Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Agreement and Plan of Merger

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Agreement and Plan of Merger

Entities:

Kyphon Inc.

Date:

2007

Size:

247KB total

Price:

$79

ID:

#2712467

 

 

► Plans ► Agreements ► Agreements & Plans of Merger
► Healthcare ► Medical Equipment & Supplies

 

 

Start of Preview


AGREEMENT AND PLAN OF MERGER

BY AND AMONG

KYPHON INC.

NEPTUNE ACQUISITION SUB, INC.

AND

ST. FRANCIS MEDICAL TECHNOLOGIES, INC.

AND WITH RESPECT TO ARTICLE VII ONLY

PHILIP M. YOUNG

AS STOCKHOLDERS REPRESENTATIVE

Dated as of December 4, 2006


TABLE OF CONTENTS

 

          Page

ARTICLE I. THE MERGER

   1

    1.1  

   The Merger    1

1.2  

   Effective Time; Closing    1

1.3  

   Effect of the Merger    2

1.4  

   Certificate of Incorporation and Bylaws    2

1.5  

   Directors and Officers    2

1.6  

   Effect on Capital Stock    2

1.7  

   Additional Merger Consideration    4

1.8  

   Surrender of Certificates    8

1.9  

   No Further Ownership Rights in Company Capital Stock    10

1.10

   Lost, Stolen or Destroyed Certificates    10

1.11

   Further Action    11

ARTICLE II. REPRESENTATIONS AND WARRANTIES OF THE COMPANY

   11

2.1  

   Organization; Standing and Power; Charter Documents; Subsidiaries    11

2.2  

   Capital Structure    12

2.3  

   Authority; Non-Contravention; Necessary Consents    14

2.4  

   Financial Statements    15

2.5  

   Corporate Governance    16

2.6  

   Undisclosed Liabilities    16

2.7  

   Absence of Certain Changes or Events    17

2.8  

   Taxes    17

2.9  

   Intellectual Property    20

2.10

   Compliance; Permits    24

2.11

   Litigation    25

2.12

   Brokers and Finders Fees; Fees and Expenses    25

2.13

   Employee Benefit Plans    25

2.14

   Real Property    29

2.15

   Assets    29

2.16

   Environmental Matters    29

2.17

   Contracts    30

2.18

   Regulatory Compliance    32

2.19

   Health Care Compliance    33

2.20

   Insurance    34

2.21

   Interested Party Transactions    34

2.22

   Customers and Suppliers    35

ARTICLE III. REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB

   35

 

-i-


TABLE OF CONTENTS

(Continued)

 

          Page

    3.1  

   Organization; Standing and Power; Charter Documents; Subsidiaries    35

3.2  

   Merger Sub    36

3.3  

   Authority; Non-Contravention; Necessary Consents    36

3.4  

   Compliance; Permits    37

3.5  

   Litigation    37

3.6  

   SEC Filings; Financial Statements    37

3.7  

   Absence of Certain Changes or Events    39

3.8  

   Intellectual Property    39

3.9  

   Availability of Funds    40

ARTICLE IV. CONDUCT BY THE COMPANY PRIOR TO THE EFFECTIVE TIME

   41

4.1  

   Conduct of Business by the Company    41

ARTICLE V. ADDITIONAL AGREEMENTS

   44

5.1  

   Acquisition Proposals    44

5.2  

   Information Statement    45

5.3  

   Stockholder Approval    45

5.4  

   Confidentiality; Access to Information; No Modification of Representations, Warranties or Covenants    45

5.5  

   Public Disclosure    46

5.6  

   Regulatory Filings; Reasonable Best Efforts    46

5.7  

   Employee Benefits    48

5.8  

   Indemnification    51

5.9  

   Certain Tax Matters    52

5.10

   Third Party Consents    54

5.11

   Merger Sub Compliance    54

5.12

   Termination of Credit Facility    55

ARTICLE VI. CONDITIONS TO THE MERGER

   55

6.1  

   Conditions to the Obligations of Each Party to Effect the Merger    55

6.2  

   Additional Conditions to the Obligations of the Company    55

6.3  

   Additional Conditions to the Obligations of Parent and Merger Sub    56

ARTICLE VII. SURVIVAL OF REPRESENTATIONS AND WARRANTIES; ESCROW

   57

7.1  

   Definitions    57

7.2  

   Survival of Representations and Warranties    59

7.3  

   Representative Reimbursement Amount Deposit    59

7.4  

   Set-Off From Earnout Amount    59

 

-ii-


TABLE OF CONTENTS

(Continued)

 

          Page

    7.5  

   Exclusive Remedy    61

7.6  

   Distribution of Earnout Amount    61

7.7  

   Stockholders Representative    62

7.8  

   Third-Party Claims    63

7.9  

   No Other Representations and Warranties    64

7.10

   Resolution of Claims    65

ARTICLE VIII. TERMINATION, AMENDMENT AND WAIVER

   65

8.1  

   Termination    65

8.2  

   Notice of Termination; Effect of Termination    66

8.3  

   Fees and Expenses    67

8.4  

   Amendment    67

8.5  

   Extension; Waiver    67

ARTICLE IX. GENERAL PROVISIONS

   67

9.1  

   Notices    67

9.2  

   Interpretation; Knowledge    68

9.3  

   Counterparts    70

9.4  

   Entire Agreement; Third-Party Beneficiaries    70

9.5  

   Severability    70

9.6  

   Other Remedies    70

9.7  

   Governing Law    70

9.8  

   Consent to Jurisdiction    71

9.9  

   Rules of Construction    71

9.10

   Assignment    71

9.11

   No Waiver    71

 

-iii-


Exhibits

 

Exhibit A

   Form of Management Escrow Agreement

Exhibit B

   Form of Closing Certificate

Exhibit C

   Form of Parachute Payment Waiver

Exhibit D

   Form of Legal Opinion

 

-iv-


Index of Defined Terms

 

Term

   Section

Acquisition Proposal

   5.1(a)

Action

   7.1

Action of Divestiture

   5.6(e)

Affiliate

   9.2(b)

Agreement

   Preamble

Assets

   2.15

Cash Payment Right

   1.6(d)

Certificate of Merger

   1.2

Certificates

   1.8(c)

Change of Control

   1.7(a)

Claim

   7.10(a)

Closing

   1.2

Closing Certificate

   1.6(f)

Closing Date

   1.2

Closing Expenses

   7.1

Code

   1.8(d)

Company

   Preamble

Company Balance Sheet

   2.4

Company Benefit Plans

   2.13(b)(i)

Company Board Recommendation

   2.3(a)(iv)

Company Business

   2.9(a)(i)

Company Capital Stock

   1.6(a)

Company Charter Documents

   2.1(b)

Company Common Stock

   1.6(a)

Company Disclosure Letter

   Article II Preamble

Company Indemnified Liabilities

   5.8(a)

Company Indemnified Parties

   5.8(a)

Company Indemnified Proceedings

   5.8(a)

Company Intellectual Property

   2.9(a)(v)

Company IP Contract

   2.9(a)(ii)

 

-v-


Term

   Section

Company Material Contract

   2.17(a)

Company Option

   1.6(d)

Company Option Plan

   1.6(d)

Company Participants

   5.7(a)

Company Permits

   2.10(b)

Company Preferred Stock

   2.2(a)(ii)

Company Products

   2.9(a)(iii)

Company Registered Intellectual Property

   2.9(a)(vi)

Company Restricted Stock

   5.7(f)(ii)

Company Stockholder

   7.1

Confidentiality Agreement

   5.4(a)

Contract

   2.2(a)

Credit Facility

   5.12

D&O Insurance

   5.8(c)

Deductible Amount

   7.4(b)

Deferred Payments

   1.7(b)(i)

Delaware Law

   Recitals

DGCL

   1.6(c)(i)

Disputed Items

   1.7(c)(ii)

Dispute Notice

   1.7(c)(ii)

Dissenting Shares

   1.6(c)(i)

DOJ

   5.6(a)(i)

Earnout Amount

   1.7(a)

Earnout Revenue

   1.7(a)

Earnout Statement

   1.7(c)(i)

Effective Time

   1.2

Employee

   2.13(a)(ii)

End Date

   8.1(c)

Environmental Laws

   2.16(i)

ERISA

   2.13(b)(i)

ERISA Affiliate

   2.13(b)(i)

 

-vi-


Term

   Section

Exchange Agent

   1.8(a)

Exchange Fund

   1.8(b)

FDA

   2.18(a)

Final Deferred Payment

   1.7(b)(i)(2)

Financial Statements

   2.4

Financing

   3.9

Financing Commitment

   3.9

First Deferred Payment Date

   1.7(a)

First Earnout Amount

   1.7(a)

First Earnout Revenue

   1.7(a)

FTC

   5.6(a)(i)

GAAP

   2.4

Governmental Consents

   6.1(b)

Governmental Entity

   2.3(c)

Hazardous Materials

   2.16(a)(ii)

Health Care Laws

   2.19(b)

HSR Act

   2.3(c)

Indemnification Termination Date

   7.1

Indemnified Parties

   7.1

Information Statement

   5.2

Initial Deferred Payment

   1.7(b)(i)(1)

Intellectual Property

   2.9(a)(iv)

International Employee Plan

   2.13(g)

IPD Devices

   1.7(a)

IRS

   7.1

Knowledge

   9.2(c)

Leased Real Property

   2.14

Leases

   2.14

Legal Proceedings

   2.11

Legal Requirements

   2.2(d)

Lender

   3.9

 

-vii-


Term

   Section

Liens

   2.1(c)

Losses

   7.1

Management Escrow Agreement

   1.6(d)

Management Shares

   5.7(f)(ii)

Material Adverse Effect

   9.2(d)

Merger

   1.1

Merger Consideration

   7.1

Merger Sub

   Preamble

Necessary Consents

   2.3(c)

Neutral Arbitrator

   1.7(c)(iii)

Objection Notice

   7.10(a)

Officers Certificate

   7.1

Option Shares

   1.6(d)

Outstanding Shares

   7.1

Parachute Payment Waiver

   5.10(f)

Parent

   Preamble

Parent Balance Sheet

   3.6(b)

Parent Disclosure Letter

   Article III Preamble

Parent ESPP

   5.7(b)

Parent Financials

   3.6(b)

Parent Permits

   3.4(b)

Parent SEC Reports

   3.6(a)

Per Share Consideration

   7.1

Per Share Earnout Amount

   1.7(a)

Permits

   2.10(b)

Person

   9.2(e)

Post-Closing Tax Period

   7.1

Pre-Closing Tax Period

   7.1

Pro Rata Portion

   7.1

Programs

   2.19(a)

Registered Intellectual Property

   2.9(a)(vii)

 

-viii-


Term

   Section

Representative Reimbursement Amount

   7.1

Resolution Period

   1.7(c)(ii)

Revenue

   1.7(a)

Safety Notices

   2.18(h)(i)

Second Deferred Payment Date

   1.7(a)

Second Earnout Amount

   1.7(a)

Second Earnout Revenue

   1.7(a)

Series A Preferred Stock

   1.6(a)

Series B Preferred Stock

   1.6(a)

Series C Preferred Stock

   1.6(a)

Significant Customer

   2.22(a)

Significant Supplier

   2.22(b)

Specified Persons

   1.7(a)

Stockholder Approval

   Recitals

Stockholders Representative

   7.7(a)

Stockholders Representative Expenses

   7.7(b)

Straddle Period

   7.1

Subsidiary

   2.1(a)

Subsidiary Charter Documents

   2.1(b)

Surviving Corporation

   1.1

Tax

   2.8(a)

Taxes

   2.8(a)

Tax Claim

   5.9(c)

Tax Period

   7.1

Tax Returns

   2.8(b)(i)

Third Party Claim

   7.8

Threshold Amount

   7.4(b)

Transaction Costs

   8.3

Transfer Taxes

   5.10(d)

Treasury Regulations

   2.8(b)(vii)

 

-ix-


AGREEMENT AND PLAN OF MERGER

This AGREEMENT AND PLAN OF MERGER (this Agreement) is made and entered into as of December 4, 2006, by and among Kyphon Inc., a Delaware corporation (Parent), Neptune Acquisition Sub, Inc., a Delaware corporation and direct wholly-owned subsidiary of Parent (Merger Sub), and St. Francis Medical Technologies, Inc., a Delaware corporation (the Company), and with respect to Article VII only, Philip M. Young, as Stockholders Representative.

RECITALS

A. The respective Boards of Directors of Parent, Merger Sub and the Company have deemed it advisable and in the best interests of their respective corporations and stockholders that Parent and the Company consummate the business combination and other transactions provided for herein in order to advance their respective long-term strategic business interests.

B. The respective Boards of Directors of Parent, Merger Sub and the Company have approved, in accordance with applicable provisions of the laws of the State of Delaware (Delaware Law), this Agreement and the transactions contemplated hereby, including the Merger (as defined in Section 1.1).

C. Promptly following the execution and delivery of this Agreement, stockholders of the Company representing the requisite number of shares of each class of the Companys capital stock will, through an action by written consent (the Stockholder Approval), adopt this Agreement.

D. Parent, Merger Sub and the Company desire to make certain representations, warranties and agreements in connection with the Merger and also to prescribe certain conditions to the Merger.

NOW, THEREFORE, in consideration of the covenants, promises and representations set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

ARTICLE I.

THE MERGER

1.1 The Merger. At the Effective Time and subject to and upon the terms and conditions of this Agreement and the applicable provisions of Delaware Law, Merger Sub shall be merged with and into the Company (the Merger), the separate corporate existence of Merger Sub shall cease and the Company shall continue as the surviving corporation. The Company, as the surviving corporation after the Merger, is hereinafter sometimes referred to as the Surviving Corporation.

1.2 Effective Time; Closing. Subject to the provisions of this Agreement, the parties hereto shall cause the Merger to be consummated by filing a Certificate of Merger with the Secretary of State of the State of Delaware in accordance


with the relevant provisions of Delaware Law (the Certificate of Merger) (the time of such filing with the Secretary of State of the State of Delaware (or such later time as may be agreed in writing by the Company and Parent and specified in the Certificate of Merger) being the Effective Time) as soon as practicable on or after the Closing Date (as defined below). The closing of the Merger (the Closing) shall take place at the offices of Wilson Sonsini Goodrich & Rosati, Professional Corporation, located at One Market, San Francisco, California, at a time and date to be specified by the parties, which shall be no later than the second business day after the satisfaction or waiver of the conditions set forth in Article VI (other than those that by their terms are to be satisfied or waived at the Closing), or at such other time, date and location as the parties hereto agree in writing. The date on which the Closing occurs is referred to herein as the Closing Date.


 

End of Preview

 

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents